Pennsylvania collaborating physician requirements apply to one of the largest healthcare markets in the country. Pennsylvania is a reduced-practice authority state for nurse practitioners, meaning CRNPs (Certified Registered Nurse Practitioners) must practice under a written collaborative agreement with a licensed physician to diagnose patients, prescribe medications, and manage clinical care. Every NP-operated clinic in Pennsylvania that prescribes medications depends on a properly structured physician collaboration to operate lawfully.
For physicians considering this type of supplemental role, the documentation requirements in Pennsylvania are specific and actively enforced by two separate regulatory bodies. Getting the agreement right from the start, understanding where it must be filed, and knowing what ongoing obligations it creates are all necessary before signing anything. This guide covers every requirement a physician needs to understand in 2026.
Pennsylvania Collaborating Physician Overview: Where Pennsylvania Stands
Pennsylvania places CRNPs in the reduced-practice category. That classification means physician collaboration is required for CRNPs who prescribe medications, with no pathway to full independent practice regardless of years of experience. The requirement does not expire after accumulating practice hours, the way states like New York or Illinois have established. In Pennsylvania, collaboration is a career-long condition for CRNPs with prescriptive authority.
Governing Bodies
Two regulatory bodies govern these arrangements:
- Pennsylvania State Board of Nursing: Governs CRNP certification, prescriptive authority approval, and collaborative agreement requirements under 49 Pa. Code Chapter 21.
- Pennsylvania State Board of Medicine: Governs physician licensure, standards of practice, and the physician’s obligations within the collaborative relationship under 49 Pa. Code Chapter 16.
Both boards can investigate compliance failures independently. A complaint filed against a CRNP can surface questions about the collaborating physician’s documentation and vice versa.
Who Qualifies as a Collaborating Physician in Pennsylvania
A Pennsylvania collaborating physician must hold a current, active, and unrestricted license to practice medicine in the Commonwealth. Under 49 Pa. Code § 21.282a, a CRNP may collaborate only with physicians who hold a current license to practice in this Commonwealth. A physician whose license is under a current disciplinary order, suspended, or inactive is not eligible to serve as a collaborating physician.
Pennsylvania does not impose a blanket specialty alignment requirement for most outpatient collaboration arrangements. However, the collaboration must be genuine. The physician must have the clinical knowledge to provide real oversight of the NP’s practice area. For high-risk settings such as psychiatric practice or controlled substance-heavy clinics, specialty alignment becomes practically significant even when it is not an absolute statutory requirement.
The Prescriptive Authority Collaborative Agreement: Pennsylvania’s Core Compliance Document
Pennsylvania uses the term Prescriptive Authority Collaborative Agreement, commonly referred to as a PACA. This is the written legal instrument that defines three things:
- The scope of the CRNP’s prescribing authority
- The physician’s oversight obligations
- The operational framework for the collaboration
Without a current, signed, and properly filed PACA, the CRNP has no authority to prescribe medications or controlled substances under Pennsylvania law. Under 49 Pa. Code § 21.283(a), a CRNP with prescriptive authority approval may, when acting in collaboration with a physician as set forth in a prescriptive authority collaborative agreement and within the CRNP’s specialty, prescribe and dispense drugs and give written or oral orders for drugs and other medical therapeutic or corrective measures. The PACA is not a background document. It is the legal foundation of every prescription the CRNP writes under the physician’s oversight.
What Must Be in a Pennsylvania PACA
Pennsylvania law specifies the minimum content requirements for a valid prescriptive authority collaborative agreement under 49 Pa. Code § 21.285. The agreement must contain all of the following:
1. Full Party Identification
The agreement must be in writing and identify all parties, including the collaborating physician, the CRNP, and at least one substitute physician who will provide collaboration if the primary physician is unavailable. It must include the signatures of both the physician and the CRNP, along with the date the agreement is signed and the date it becomes effective.
2. CRNP Specialty Designation
The agreement must identify the specialty in which the CRNP is certified. A CRNP practices within the scope of a specific specialty, and the collaborative agreement must reflect that scope. A PACA that does not match the CRNP’s certified specialty creates a compliance gap before any prescription is written.
3. Authorized Drug Categories
The agreement must identify the categories of drugs from which the CRNP may prescribe or dispense. Pennsylvania uses a formulary structure based on the American Hospital Formulary Service Pharmacologic-Therapeutic Classification. The CRNP’s prescribing is limited to the categories listed in the agreement unless it is updated.
4. Physician Patient Contact Terms
The agreement must specify the circumstances and how often the collaborating physician will personally see patients. The frequency and conditions are determined by the parties, but they must be written into the agreement explicitly. Leaving this section vague or blank creates ambiguity that becomes a compliance problem during any board review.
5. CRNP Liability Insurance Coverage
The agreement must specify the amount of professional liability insurance coverage carried by the CRNP. This is a mandatory element of the agreement, not an optional disclosure.
Filing Requirements: Where the Agreement Goes
Pennsylvania has a specific filing obligation that distinguishes it from several other states. Under 49 Pa. Code § 21.285(a)(5), the PACA must be kept at the primary practice location of the CRNP and a copy filed with the Bureau of Professional and Occupational Affairs.
The Dual Filing Requirement
This creates two separate obligations:
- The agreement must be physically accessible at the practice location for any inspection or investigation.
- A copy must be filed with the BPOA before the CRNP begins prescribing under the agreement. This is not a post-practice administrative step. It is a prerequisite.
The agreement must also be made available for inspection to anyone who requests it, and provided without charge to any licensed pharmacist or pharmacy upon request. A PACA is a semi-public document in Pennsylvania. Physicians who enter into collaborative agreements should understand that the document’s terms can be reviewed by third parties, including pharmacists verifying a CRNP’s prescribing scope.
When the Agreement Changes or Ends
When a PACA is updated or terminated, the CRNP must notify the Pennsylvania State Board of Nursing in writing and file the Change of Prescriptive Authority Collaborative Agreement form along with the amended agreement. This filing obligation applies any time:
- The scope of practice changes
- A practice location is added
- The collaboration ends
Review and Renewal
Pennsylvania requires the PACA to be reviewed and updated by both parties at least once every two years, or whenever the agreement is changed. The two-year review cycle is a minimum, not a maximum. If the scope of practice changes before the two-year mark, the agreement must be updated promptly to reflect actual practice.
Each review requires dated signatures from both the physician and the CRNP. A PACA that has not been reviewed within two years is no longer current and creates regulatory exposure for both parties.
Physician Availability and Supervision Obligations
The collaborative model in Pennsylvania is not passive. Pennsylvania defines collaboration as a process that includes the following elements under 49 Pa. Code § 21.251:
- Immediate availability of a licensed physician to a CRNP through direct communications or by radio, telephone, or telecommunications
- A physician available to a CRNP on a regularly scheduled basis for referrals and review of the standards of medical practice
- Consultation and chart review, drug and other medical protocols within the practice setting
- Periodic updating in medical diagnosis and therapeutics
These are statutory definitions of collaboration, not aspirational standards. A physician who is not genuinely available, does not conduct chart reviews on a regular schedule, and does not engage in ongoing clinical consultation is not meeting the legal definition of collaboration under Pennsylvania law, regardless of what the written agreement says.
Remote Collaboration
Remote collaboration is permitted. Pennsylvania does not impose a geographic proximity requirement. A physician in Pittsburgh can serve as a collaborating physician for a CRNP practice in Philadelphia. Distance does not reduce the supervision requirement. The availability obligation remains at full force regardless of location.
Controlled Substance Prescribing in Pennsylvania
Pennsylvania places specific limitations on CRNP prescribing of controlled substances under 49 Pa. Code § 21.284. These limits apply to all CRNPs with prescriptive authority and must be reflected accurately in the PACA.
Prescribing Limits by Schedule
| Schedule | Limit | Condition |
| Schedule I | Prohibited | No exceptions |
| Schedule II | Up to 30-day supply | Must be authorized in the PACA |
| Schedule III/IV | Up to 90-day supply | As identified in the agreement |
Refills on Schedule III and IV prescriptions require explicit physician authorization and must be documented accordingly.
Additional Requirements
- A CRNP may not delegate prescriptive authority. The authority granted under the collaborative agreement belongs exclusively to the CRNP named in that agreement.
- For controlled substance prescribing, the CRNP must hold a current DEA registration.
- The prescription must bear the CRNP’s certification number, name, and NPI, along with the DEA registration number where applicable.
Physicians who do not want to authorize controlled substance prescribing under a particular agreement need to state that exclusion explicitly in the PACA. Silence on the matter is not equivalent to exclusion.
The Physician-to-CRNP Ratio: What Changed and Why It Matters
Pennsylvania previously imposed a regulatory cap on the number of CRNPs a single physician could supervise simultaneously. That ratio restriction has been eliminated from current Pennsylvania regulations. The Pennsylvania Bulletin notes that the Board deleted the CRNP-to-physician ratio in its regulatory updates, responding to comments from health systems and educational institutions that argued the ratio restricted care delivery unnecessarily.
What the Elimination Does Not Change
Removing the ratio cap does not remove the physician’s substantive obligations. A physician who enters into an excessive number of collaborative agreements without the capacity to provide genuine availability, chart review, and oversight is not meeting the standards of the collaborative relationship, even if the number of agreements is no longer capped by regulation.
Physicians considering multiple Pennsylvania collaborations should assess their actual availability and oversight capacity. The quality of supervision is still measured against the statutory definition of collaboration, and that standard applies regardless of how many agreements a physician holds.
Common Compliance Mistakes Pennsylvania Collaborating Physicians Make
Most Pennsylvania PACA compliance problems come from documentation gaps, not intent. These are the patterns that create exposure:
- PACA not filed with the BPOA. The agreement must be kept at the practice location and a copy filed with the Bureau of Professional and Occupational Affairs. Physicians who sign an agreement without confirming that the CRNP has filed the required copy leave the arrangement without a formal record on file.
- Substitute physician not identified. The PACA must name at least one substitute physician who will provide collaboration when the primary physician is unavailable. Agreements that list only the primary physician create a coverage gap that becomes a compliance problem when the physician is out of contact.
- Drug categories not specified. The agreement must identify which drug categories the CRNP is authorized to prescribe. Generic statements that a CRNP may prescribe all medications within their specialty are insufficient. The categories must match the formulary structure used under Pennsylvania regulation.
- Schedule II authority left ambiguous. A CRNP’s authority to prescribe Schedule II controlled substances must be affirmatively identified in the PACA. Physicians who do not want to authorize Schedule II prescribing need to state that exclusion explicitly. Leaving the section blank or vague does not protect either party.
- Agreement not reviewed within the two-year cycle. The PACA must be reviewed and updated at minimum every two years, with dated signatures from both parties. Agreements that expire without renewal are not current and expose both the physician and the CRNP to disciplinary action.
- Availability not genuine. A collaborative physician who is unreachable, does not conduct chart reviews on schedule, and has no real engagement with the CRNP’s clinical practice is not meeting the statutory definition of collaboration. The agreement is only as defensible as the actual oversight behind it.
Pennsylvania Collaborating Physician Requirements: Quick Reference
Physician Eligibility
- Active, unrestricted Pennsylvania MD or DO license
- Not under a current disciplinary order affecting collaborative practice
Core Compliance Document
- Written Prescriptive Authority Collaborative Agreement (PACA) meeting all requirements of 49 Pa. Code § 21.285
- Kept at primary practice location; copy filed with the Bureau of Professional and Occupational Affairs
- Must identify all parties including a substitute physician
- Must specify drug categories, patient visit circumstances, and CRNP liability insurance
Filing Obligations
- PACA filed with BPOA before prescribing begins
- Change of Prescriptive Authority Collaborative Agreement form filed when agreement is updated or terminated
- Board of Nursing notified in writing of any updates or termination
Review Cycle
- PACA reviewed and updated at minimum every two years
- Updated whenever scope of practice, location, or parties change
Controlled Substance Limits
- Schedule II: up to 30-day supply, must be authorized in the PACA
- Schedule III/IV: up to 90-day supply, as identified in the agreement
- Schedule I: prohibited
Physician-to-CRNP Ratio
- No regulatory cap; eliminated from current regulations
Geographic Requirement
- None; remote collaboration is permitted, but genuine availability and ongoing oversight are still required
Final Thoughts
Pennsylvania collaborating physician requirements are built around documentation and genuine availability. The PACA is not a one-time administrative task. It is a living document that must reflect the actual scope of the CRNP’s practice, be filed with the appropriate authority, and be reviewed on a defined schedule. The physician’s obligation is not limited to signing the agreement. Real availability, regular chart review, and ongoing clinical engagement are what the law defines as collaboration.
For physicians entering the Pennsylvania market, the compliance framework is structured and workable when the paperwork is correct from the start. The PACA must be specific, filed properly, updated on schedule, and backed by genuine oversight. A collaboration built on that foundation holds up under scrutiny.
Build a Compliant Pennsylvania Collaboration With Collaborating Physician
If you are a licensed Pennsylvania physician interested in building a structured, compliant collaboration arrangement, Collaborating Physician handles the infrastructure so you do not have to figure it out alone.
The platform connects licensed physicians with vetted NP-operated clinics across Pennsylvania and 50-plus other states. Every agreement is structured to meet state-specific requirements, including Pennsylvania’s PACA mandates, BPOA filing obligations, and biennial review requirements. Physicians receive compliance support throughout the collaboration, not just at the start.
Applications take under ten minutes. Clinic matches typically happen within 24 to 48 hours. There is no cost to physicians at any stage.
Disclaimer: This content is for educational and informational purposes only. It does not constitute legal or medical advice. Pennsylvania healthcare regulations change frequently. Always verify current requirements directly with the Pennsylvania State Board of Nursing, the Pennsylvania State Board of Medicine, and a qualified healthcare attorney before making any practice decisions.
Frequently Asked Questions
Does a Pennsylvania collaborating physician need to be physically present at the CRNP’s clinic?
No. Pennsylvania does not impose a geographic proximity requirement on collaborating physicians. Remote collaboration is permitted. However, the physician must meet the statutory definition of collaboration, which includes immediate availability by phone or telecommunications and a regularly scheduled presence for chart review, protocol review, and clinical consultation.
How often does a Pennsylvania PACA need to be reviewed?
The Prescriptive Authority Collaborative Agreement must be reviewed and updated by both parties at least once every two years, or whenever the agreement is changed. Each review requires dated signatures from the physician and the CRNP. A PACA that has passed the two-year mark without renewal is not current.
Does the PACA need to be filed with any state board?
Yes. Under 49 Pa. Code § 21.285(a)(5), the PACA must be kept at the CRNP’s primary practice location, and a copy must be filed with the Bureau of Professional and Occupational Affairs. The filing must occur before the CRNP begins prescribing under the agreement. When the agreement is updated or terminated, the CRNP must file notification with the State Board of Nursing.
Can a Pennsylvania CRNP prescribe Schedule II controlled substances?
Yes, within limits. A CRNP may prescribe a Schedule II controlled substance for up to a 30-day supply, but only if that authority is specifically identified in the PACA. If the collaborative agreement does not address Schedule II prescribing, the CRNP has no authority to write those prescriptions. Physicians who do not wish to authorize Schedule II prescribing must state that exclusion explicitly in the agreement.
How many CRNPs can one Pennsylvania physician collaborate with?
Pennsylvania eliminated its regulatory cap on the number of CRNPs a physician may collaborate with simultaneously. There is no current ratio limit. However, the absence of a cap does not change the physician’s substantive oversight obligations. A physician must be genuinely available and provide real chart review and clinical consultation for every CRNP in every active agreement.
What happens if a Pennsylvania PACA is not compliant?
Both the physician and the CRNP can face disciplinary action from their respective boards. The State Board of Medicine can investigate the physician’s collaborative practices, and the State Board of Nursing can act against the CRNP. Compliance failures can result in license restrictions, formal board orders, and in serious cases, suspension. Maintaining a current, complete, and properly filed PACA is the most effective way to avoid regulatory exposure.
